Androgen receptor (AR) plays a critical role in the development and progression of prostate cancer, where it is a key therapeutic target. Here we report that, in contrast to estrogen receptor transcription complexes which form within minutes and recycle hourly, the levels of regulatory regions bound by AR complexes rise over a 16 hr period and then slowly decline. AR regulation of the prostate specific antigen (PSA) gene involves both a promoter-proximal sequence as well as an enhancer w4 kb upstream. Recruitment of AR and its essential coactivators at both sites creates a chromosomal loop that allows RNA polymerase II (pol II) to track from the enhancer to the promoter. Phosphorylation of the pol II C-terminal domain is required for pol II tracking but not chromosomal looping. Development of improved hormonal therapies for prostate cancer must take in account the specific spatial and temporal modes of AR-mediated gene regulation.
Introduction
The androgen receptor (AR) regulates not only development and maintenance of male reproductive functions, but myriad other sexually dimorphic processes (Quigley et al., 1995) . Changes in AR signaling pathway plays a major role in the onset and progression of prostate cancer and AR is a therapeutic molecular target (Jenster, 1999) . AR is a member of the nuclear hormone receptor (NR) superfamily that regulates the expression of target genes in a ligand-inducible manner (Mangelsdorf et al., 1995; Tsai and O'Malley, 1994) . NR coactivators, defined by their role in enhancing NR transcriptional activity, are generally divided into two families: those that modify chromatin structure, and those that recruit and modify RNA polymerase II (pol II) and general transcription factors (Glass and . However, the dynamics of long-term androgen-induced recruitment of the AR coactivator complex to PSA regulatory regions is not known. Furthermore, the mechanisms by which PSA enhancer and promoter coordinate to regulate gene transcription are controversial. Finally, the relative importance of the various endogenous AR coactivators recruited to PSA regulatory regions in regulating PSA transcription is poorly known.
Here, we describe that in contrast to ER, the occupancy of the AR coactivator complex on PSA regulatory regions increases gradually after androgen exposure, peaks at 16 hr, and then gradually declines following longer stimulation. We also find that pol II is first recruited to the PSA enhancer and then tracks along the looped chromatin upstream of the PSA promoter, providing evidence for an integrated looping/tracking model for the PSA enhancer-promoter interaction. Furthermore, we show that p160 proteins are redundant while TRAP220 is indispensable in mediating AR transcription. Collectively, these data suggest a new model for the assembly of AR coactivator complex at PSA regulatory regions. , 2002) , the distribution of AR coactivator complex association with the PSA enhancer, promoter, and region between the enhancer and promoter is less well defined. Furthermore, the temporal dynamics of AR coactivator complex recruitment to the PSA enhancer/promoter in response to long-term androgen treatment is poorly known. To address these questions, chromatin immunoprecipitation (ChIP) assays were performed to examine AR coactivator complex formation at the PSA enhancer, promoter, and the region between the enhancer and promoter. LNCaP cells were grown in hormone-free medium for 3 days and then treated with or without 100 nM dihydrotestosterone (DHT) for 4-16 hr. The formaldehyde-crosslinked chromatin-protein complexes were immunoprecipitated from LNCaP cells using specific antibodies against AR, SRC1, GRIP1, AIB1, p300, TRAP220, CARM1, AcH3, TBP, pol II, and phosphorylated pol II. The immunoprecipitated DNA was subsequently analyzed by quantitative PCR or standard PCR using primers spanning the PSA enhancer, promoter, and the intervening middle region. The results were analyzed as either percentage of immunoprecipitated DNA versus total input DNA or fold enrichment after immunoprecipitation relative to untreated control. Consistent with previous studies (Jia et al., 2004; Louie et al., 2003) , AR and associated HAT complexes were recruited to the PSA enhancer and promoter, resulting in increases in AcH3 upon short-term (4 hr) DHT treatment ( Figure 1A) . Interestingly, the level of recruitment to the PSA enhancer was significantly greater than to the promoter ( Figure 1B) . The Mediator component TRAP220 was not only recruited to the PSA enhancer (Wang et al., 2002) , but also enriched on the PSA promoter in response to 4 hr DHT treatment ( Figures 1A and 1B) . The histone methyltransferase CARM1 has been found to be an AR coactivator (Chen et al., 1999) . We found CARM1 to be recruited to the PSA enhancer but not the promoter after 4 hr DHT treatment ( Figures 1A and  1B) . Interestingly, the general transcription factor TATA binding protein (TBP) bound at the PSA enhancer and promoter simultaneously and androgen induced greater TBP occupancy on the enhancer than promoter ( Figure  1B ). When we examined the presence of AR, HATs, Mediator, CARM1, AcH3, and TBP to the middle region between the PSA enhancer and promoter (2 kb away from both the enhancer and the promoter), we did not find significant enrichment of these proteins after 4 hr DHT stimulation ( Figure 1B) . Strikingly, both unphosphorylated and phosphorylated pol II were recruited to the PSA enhancer and promoter after 4 hr DHT treatment, but not to an upstream region (1.5 kb away from the PSA enhancer) (Figures 1C and 1D) . In contrast to AR, coactivators, and AcH3, the relative abundance of pol II was higher on the promoter than on the enhancer, in agreement with prior studies (Kang et al., 2004) . While the relative abundance of pol II on the middle region was significantly lower than that on the enhancer and promoter, surprisingly there was 2-to 5-fold enrichment of pol II on the middle region between the enhancer and promoter after 4 hr DHT treatment relative to untreated control ( Figure 1D) .
Results

Analysis of the
In contrast to ER where occupancy peaks very rapidly, the recruitment of AR, HATs, Mediator, AcH3, pol II, and phosphorylated pol II but not CARM1 to the PSA enhancer and promoter gradually increased in response to long-term androgen treatment (4-16 hr) (Figure 1B) . Long-term androgen treatment also led to a gradual enrichment of pol II and phosphorylated pol II on the middle region ( Figures 1C and 1D ). To further address the effect of long-term androgen treatment on AR coactivator complex assembly on PSA regulatory regions, LNCaP cells were treated with DHT for 24-96 hr and ChIP assays were carried out using primers spanning the PSA enhancer (Figure 2A do not slide through the DNA between the enhancer and promoter. In addition, TBP, which binds to the TATA sequence located w25 bp upstream of PSA transcription initiation site, was detected on both the PSA enhancer and promoter ( Figure 1B ). In contrast, pol II recruitment to the middle region followed the same pattern as its binding to the enhancer and the promoter after long-term androgen exposure, especially when the data are analyzed as fold enrichment following DHT treatment ( Figure 1D ). We also examined the timing of the recruitment of pol II to the enhancer, middle region, and promoter following brief exposure of LNCaP cells to DHT (10 min, 30 min, 1 hr, and 4 hr) using anti-pol II antibodies ( Figure 1E ). Interestingly, we find pol II is first recruited to the PSA enhancer, then to the middle region, and finally to the promoter region. The recruitment to all three regions reaches a steady state following prolonged androgen treatment (4 hr). These data support the conclusion that pol II tracks from the PSA enhancer to the promoter.
To provide further evidence that looping occurs in vivo, we performed ChIP combined chromosome conformation capture assay (ChIP-3C) (Dekker et al., 2002; Horike et al., 2005). If the distal PSA enhancer is physically located close to the proximal PSA promoter due to looping, fragments of the enhancer and promoter generated by digestion with the same restriction enzyme should be able to be ligated and detected by PCR. Hormone-depleted LNCaP cells were treated with or without DHT for 4 hr. The crosslinked chromatin was digested with BstYI, immunoprecipitated with an anti-AR antibody, and ligated. After reversing crosslinking, PCR was performed with one primer in the PSA enhancer and another in the PSA promoter (primer E+/P−). As shown in Figure 3A , the PSA enhancer and promoter interacted in a ligase-dependent manner and this interaction was enhanced by androgen treatment. The specific 612 bp primer E+/P−-amplified band was sequenced and confirmed the interaction between the PSA enhancer and promoter. In addition, several larger PCR products were seen, which are the result of incompletely digested chromatin. In contrast, E+ combined with a primer from the middle region (J−) did not give rise to a specific product, suggesting that the loop is Figure 3B ). These constructs were transiently transfected into LNCaP cells and luciferase was measured after 24 hr DHT stimulation. As shown in Figure 3B , the transcriptional activity was enhanced 18.7-fold from a control PSA-Luc construct (construct a), compared to 9.1-fold for a PSA-Luc construct with an FII insulator inserted between the enhancer and the promoter (construct b) and 11.7-fold for a PSA-Luc construct with an FII insulator placed outside the enhancer (construct d). As expected, transcription activation was further decreased to 6.4-fold from a PSA-Luc construct with an FII insulator on both sides of the enhancer (construct e). Two copies of FII outside the enhancer plus one copy of FII inserted between the enhancer and the promoter possessed the highest enhancer blocking activity (construct f, transactivation fold 3.7), indicating that the insulator dosage correlates with enhancer blocking activity. The sequence specificity of FII is crucial for enhancer blocking because a mutated FII inserted between the PSA enhancer and the promoter was devoid of blocking activity (construct c, transactivation fold 22.5). Insertion of an FII insulator downstream of an isolated PSA enhancer reporter gene, which can mediate a robust androgen-induced transcription activity similar to a fulllength PSA promoter (construct g), also inhibited transcriptional activity to one-half (construct h). These results suggest that insulators block the transmission of signals from the PSA enhancer to the promoter and luciferase gene. Our evidence in Figure 1 showing that pol II tracks between the enhancer and promoter makes it a likely candidate to be the signal blocked by the insulator. 
Mechanisms for AR Transcription Complex Assembly
In an effort to investigate the underlying mechanisms for long-term AR coactivator complex assembly, we first examined the effects of long-term androgen treatment on expression levels of AR, coactivators, and pol II. LNCaP cells were treated with either DHT or ethanol control for 4-96 hr. Western blot analyses were performed using antibodies against AR, p160 proteins, p300, TRAP220, and pol II. In agreement with a previous report (Wolf et al., 1993) 4B). In contrast to androgen treatment alone in which greater levels of pol II were detected at the promoter as compared with the enhancer, DRB treatment resulted in a greater decrease in pol II occupancy at the promoter than the enhancer, reversing the ratio ( Figure 4B ). These data suggest DRB may inhibit pol II tracking from the enhancer to the promoter, which is consistent with the report of Louie et al. (2003) showing that another CTD kinase inhibitor, flavopiridol, perturbs pol II's transfer. Consistent with the significantly decreased binding of coactivators and pol II to PSA regulatory regions, PSA RNA synthesis was completely blocked by DRB treatment (Figure 4C) . Interestingly, AR recruitment was not affected by DRB treatment after 4-8 hr DHT stimulation, and it was only significantly diminished at 16 hr of DHT exposure ( Figure 4B ). While DRB treatment did not significantly affect AR, coactivator, and unphosphorylated pol II protein levels after 4-8 hr DHT stimulation, it reduced protein levels after 16 hr DHT treatment ( Figure 4D) . Thus, the reduced AR recruitment following 16 hr DHT treatment may be caused by the downregulation of AR protein levels. These results suggest that pol II CTD phosphorylation is required for efficient AR coactivator and pol II association with PSA regulatory regions but not AR itself.
Because DRB blocks pol II tracking and PSA RNA production, we next addressed whether DRB affects PSA enhancer/promoter loop formation. We pretreated LNCaP cells with DRB or vehicle for 1 hr followed by ChIP-3C assay. As shown in Figure 4E , treatment of cells with DRB had no effect on interaction between the PSA enhancer and promoter, suggesting that tracking is not required for looping.
Histone acetylation is correlated to gene expression and histone deacetylation is linked to gene silencing (Hu and Lazar, 2000; Struhl, 1998). We have previously showed that a histone deacetylase inhibitor, trichostatin (TSA), can enhance androgen-induced transcriptional activity (Shang et al., 2002) Figure 5B , silencing of SRC1 or GRIP1 did not attenuate PSA hnRNA production after DHT treatment for 4-16 hr when compared with a control siRNA (siLuc). Silencing of AIB1 or CARM1 had a modest effect. PSA hnRNA levels decreased significantly following 4-8 hr DHT treatment when p300 was silenced. However, after 16 hr androgen treatment, the PSA hnRNA levels in p300 silenced cells were similar to those in siLuc transfected control cells. Significantly, silencing of TRAP220 had a potent effect in reducing PSA hnRNA production following 4-16 hr androgen stimulation. These findings indicate that SRC1, GRIP1, AIB1, and CARM1 are not essential, whereas p300 (in an early phase) and TRAP220 are crucial in androgen-mediated PSA gene activation.
We next asked why silencing of SRC1 failed to inhibit AR-mediated PSA gene transcription. LNCaP cells were transiently transfected with either siSRC1 or control siLuc, cultured for 48 hr, and then treated with DHT for 16 hr. Western blot analyses showed that while SRC1 silencing had no major effect on AR and pol II expression levels, it led to a modest increase of GRIP1 and AIB1 expression levels ( Figure 5C, left) . We next performed ChIP assays to study the effects of SRC1 silencing on AR coactivator complex recruitment to PSA regulatory regions. As shown in Figure 5C (left and right), recruitment of SRC1 to the PSA enhancer was greatly decreased in SRC1 silenced cells as compared with the robust recruitment of SRC1 to the PSA enhancer in siLuc transfected cells. Interestingly, the association of GRIP1 and AIB1 with the PSA enhancer was modestly increased, leading to a modest increase in AcH3 at the PSA enhancer ( Figure 5C, right) . Pol II and TBP recruitment to the PSA enhancer and promoter in siSRC1 transfected cells were not changed compared with siLuc transfection control ( Figure 5C , right). These data suggest that a compensatory elevation of GRIP1 and AIB1 recruitment to the PSA enhancer may contribute to the failure of SRC1 silencing to attenuate PSA gene transcription.
To investigate the mechanism of PSA RNA inhibition by TRAP220 silencing, we transiently transfected siTRAP220 into LNCaP cells, cultured the cells for 48 hr, and then treated cells with DHT for 16 hr. In cells transfected with siTRAP220, the expression levels of SRC1, AR, and pol II were similar to those in siLuc transfected cells (Figure 5D, left) . ChIP analyses showed attenuated recruitment of TRAP220 to the PSA enhancer in siTRAP220 transfected cells as compared with the siLuc transfected control ( Figure 5D, left and right) . The recruitment of AR, SRC1, AcH3, and TBP to PSA enhancer in siTRAP220 transfected cells was similar to that in siLuc transfected cells (Figure 5D, right) . In contrast, silencing TRAP220 led to a modest decrease in TBP association with the PSA promoter and pol II association with the PSA enhancer and middle region. Moreover, the recruitment of pol II to the PSA promoter was significantly reduced in siTRAP220 transfected cells (Figure 5D, right) . These results indicate that Mediator facilitates the occupancy of pol II and TBP on PSA regulatory regions, which is essential for AR-mediated transcription. Figure 3B ) also could reduce AR-mediated transcription to one-half, making it unlikely that insulators act to block looping. Furthermore, we found that in a construct containing only an isolated PSA enhancer and no defined promoter element (construct h) in which loop formation is unlikely, an insulator could also suppress transcription ( Figure 3B) . These results suggest that insulators may block signals that track from an enhancer in both directions in transiently transfected circular plasmids. Based on our ChIP data, 3C experiments, and insulator studies, we conclude that pol II tracks through a large loop formed between the PSA enhancer and promoter ( Figure 6B ). Such a combined looping/ tracking model is different from a facilitated tracking model that proposes transcription complexes bound to the enhancer all track to the promoter through small loops (Blackwood and Kadonaga, 1998) . In addition, our combined looping/tracking model cannot exclude a linking model in which unidentified proteins (Bulger and Groudine, 1999) may facilitate PSA enhancer/promoter looping.
Discussion
Recent studies found that distal enhancer-bound pol II could be phosphorylated and that this may be important for pol II tracking from the enhancer to the promoter (Johnson et al., 2001; Louie et al., 2003) . We found phosphorylated pol II was recruited to the PSA enhancer, the promoter, and the middle region after androgen stimulation (Figures 1C and 1D) . When pol II CTD phosphorylation was inhibited by DRB, we found that not only was pol II transfer from the enhancer to the promoter blocked but also that the recruitment of SRC1, p300, TRAP220, and AcH3 to the enhancer was decreased ( Figure 4B) . A possible explanation is that inhibition of pol II CTD phosphorylation may reduce HAT recruitment to the PSA enhancer, which in turn decreases Mediator recruitment and histone hyperacety-lation. However, AR recruitment to PSA enhancer was not affected by either pol II CTD phosphorylation or histone acetylation (Figures 4B and 4F) , consistent with the notion that chromatin remodeling is not crucial for some activators binding to nucleosomal DNA (Orphanides and Reinberg, 2002).
The p160 proteins play a scaffold role in forming coactivator complex involved in NR-mediated transcription (Shang et al., 2000, 2002) . However, examples of p160 protein redundancy have been documented. For example, an increase in GRIP1 in SRC1 knockout mice partially compensates for the loss of SRC1 function in target tissues (Xu et al., 1998) . Using a re-ChIP approach, Metivier et al. (2003) found SRC1 and AIB1 are never found on the same site of an estrogen responsive promoter, suggesting a degree of functional redundancy between these two proteins. Our finding that silencing of SRC1 failed to inhibit AR-mediated transcription and led to increased GRIP1 and AIB1 recruitment to the PSA enhancer also suggests that some degree of functional redundancy exists among the p160 proteins. Conversely, we found TRAP220 is indispensable for AR-mediated transcription. siRNA-ChIP analysis demonstrated that inhibition of TRAP220 resulted in less pol II recruitment to the PSA enhancer/promoter, which is consistent with the hypothesis that Mediator facilitates recruitment of pol II into transcription preinitiation complexes (Malik and Roeder, 2000) . Given that TRAP220 anchors the Mediator complex to AR, our finding that silencing TRAP220 led to less TBP recruitment to the PSA promoter is relevant to a previous report demonstrating that occupancy of TATA by TBP is dependent on Mediator Srb4 (yeast homolog of TRAP80) in yeast (Kuras and Struhl, 1999) .
In summary, our findings illuminate a comprehensive model of AR coactivator complex assembly at PSA regulatory regions. Unlike other nuclear receptors such as ER, AR activity involves sustained chromatin association and transcriptional activation of target genes for more than 96 hr. This activity of AR is dependent on phosphorylated pol II tracking from the PSA enhancer to the promoter through looped DNA and on members of the Mediator complex. Improved hormonal therapies for prostate cancer may be able to exploit these unique aspects of AR-dependent gene regulation. 
Chromatin Immunoprecipitation
Chromatin immunoprecipitation (ChIP) was performed as previously described (Shang et al., 2002) with a few modifications.
Briefly, chromatin was crosslinked for 10 min at room temperature with 1% formaldehyde directly added to cell culture medium. The crosslinked chromatin was sonicated, diluted, and immunoprecipitated with specific antibodies at 4°C overnight. Protein A-Sepharose beads were added and then washed sequentially with low-salt buffer, high-salt buffer, LiCl buffer, and TE buffer. The protein-DNA complexes were eluted and the crosslinking was reversed at 65°C for 15 hr. DNA fragments were purified and analyzed by either realtime PCR or regular PCR. For real-time PCR, the SYBR Green PCR kit (Applied Biosystems, Foster City, CA) was used and the samples were amplified with the ABI Prism 7700 Sequence Detector (Applied Biosystems). The primers used in real-time PCR are listed in Figure S4 (in the Supplemental Data available with this article online). For regular PCR, PCR was performed for 25-35 cycles and the primer sequences for enhancer (E+/E−) and promoter (P+/P−) were as described in Figure S4 .
Real-Time RT-PCR
Total RNA from LNCaP cells was isolated using an RNeasy kit (Qiagen, Valencia, CA). Real time RT-PCR was performed on 100 ng of RNA by using SYBR Green PCR kit and MultiScribe reverse transcriptase (Applied Biosystems) according to the manufacturer's protocol. The primers for PSA mRNA and PSA hnRNA are listed in Figure S4 .
ChIP Combined Chromosome Conformation Capture Assay (ChIP-3C)
The crosslinked chromatin was sonicated, digested with specific restriction enzymes overnight, and immunoprecipitated with anti-AR antibodies coupled to protein A beads. The beads were then precipitated, resuspended in ligation buffer, and overnight ligation was performed. The beads were washed and protein-DNA complexes were eluted. The crosslinking was reversed and ligated DNA was purified. The PCR primers (E+, E−, J−, Q−, and P−) for amplifying ligated DNA were as described in Figure S4 . 
Reporter Gene Assays
Transfection of hormone-depleted LNCaP cells was performed using Lipofectamine PLUS reagent (Invitrogen, Carlsbad, CA). Cells were treated with DHT for 24 hr and then harvested. Luciferase activity was measured using a luciferase kit (Promega) and transfection efficiency was normalized with β-galactosidase activity. 
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